Quantcast
Channel: MaaT013 - News, Articles etc. - European Pharmaceutical Review
Browsing all 3 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Pioneering a full-ecosystem microbiota approach to improve survival outcomes...

WE SHARE our bodies with trillions of symbiotic, commensal microorganisms – bacteria, fungi, viruses and other microbes. Collectively, they are called the human microbiota and all the genes they...

View Article


Image may be NSFW.
Clik here to view.

Microbiome biotherapeutic shows promise in acute graft-versus-host disease

MaaT Pharma has released new data from the Phase II trial evaluating MaaT013, a full-ecosystem microbiome biotherapeutic, in a high-risk patient population with grade III-IV steroid-refractory,...

View Article

Image may be NSFW.
Clik here to view.

Long-term data indicates “significant” potential of aGvHD microbiome treatment

Positive data from MaaT Pharma’s Microbiome Ecosystem TherapyTM (MET) MaaT013 as a treatment for acute graft-versus-host disease (aGvHD), is set to be presented at the 2024 European Society for Blood...

View Article
Browsing all 3 articles
Browse latest View live